SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-21-021965
Filing Date
2021-02-12
Accepted
2021-02-12 16:24:33
Documents
3
Group Members
NOVARTIS AG

Document Format Files

Seq Description Document Type Size
1 SC 13G tm216494d1_sc13g.htm SC 13G 67438
2 EXHIBIT 1 tm216494d1_ex99-1.htm EX-99.1 27314
3 EXHIBIT 2 tm216494d1_ex99-2.htm EX-99.2 6180
  Complete submission text file 0001104659-21-021965.txt   102425
Mailing Address LICHTSTRASSE 35 CH-4002 BASEL V8
Business Address LICHTSTRASSE 35 CH-4002 BASEL V8 212-830-2474
NOVARTIS PHARMA AG (Filed by) CIK: 0001030617 (see all company filings)

Type: SC 13G

Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Subject) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91606 | Film No.: 21627941
SIC: 2836 Biological Products, (No Diagnostic Substances)